About 200 reports

Global Attention-Deficit Hyperactivity Disorder (ADHD) Market: Size, Trends & Forecasts (2019-2023) May 2019 ##.

  • Neurological Disorder
  • World
  • Eli Lilly & Co.
  • Pfizer Inc.
  • Shire plc

Less substitute. ##.

  • Neurological Disorder
  • World
  • AstraZeneca PLC
  • Biogen Idec Inc.
  • Eli Lilly & Co.

Tier ##: revenue > USD ## billion; tier ##: USD ## million ≤ revenue ≤ USD ## billion; tier ##: revenue < USD ## million.

  • Neurological Disorder
  • Vitamin
  • Amway Corporation
  • ConAgra Foods, Inc.
  • The Kraft Heinz Company

Roche focuses on four major medical indications and disease areas: Oncology, Neuroscience, Viral and Bacterial Infections and Immunology.

  • Neurological Disorder
  • World
  • Biogen Idec Inc.
  • Novartis AG
  • Pfizer Inc.

TABLE ##. ##.

  • Neurological Disorder
  • Forecast
  • Market Size
  • Jazz Pharmaceuticals plc
  • Shionogi & Co., Ltd.

Annual Review of Immunology; ##: ##-## Maroney SA, et al. (2006).

  • Neurological Disorder
  • Vitamin
  • Market Size
  • Alexion Pharmaceuticals, Inc.
  • Alnylam Pharmaceuticals, Inc.

AD is one of the most common types of NDDs.

  • Neurological Disorder
  • Eli Lilly & Co.
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Merck & Co., Inc.

Revati holds a PhD in Tumor Immunology from the Tata Cancer Research Institute in Mumbai, India.

  • Neurological Disorder
  • United States
  • Biogen Idec Inc.
  • Novartis AG
  • Sanofi S.A.

Edit completed her PhD in Cancer Immunology/ Immunotherapy at St.

  • Neurological Disorder
  • Therapy
  • United States
  • Forecast
  • Genzyme Corporation

It deals in a variety of therapies of anti-infectives, inflammation and immunology, internal medicine, and oncology.

  • Vitamin
  • Amway Corporation
  • Bayer AG
  • Pfizer Inc.
  • Procter & Gamble Company

THE REVENUE FROM IMMUNOLOGY IN 2016 WAS $##, ## MILLION.

  • Neurological Disorder
  • World
  • Market Size
  • GlaxoSmithKline plc
  • Novartis AG

VIMPAT is one of the recently launched drugs.

  • Neurological Disorder
  • Daiichi Sankyo Company
  • Eisai Co., Ltd.
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • 9 Appendix

PloS one; ##(##): e##, ##-## Montouris G, et al. (2015).

  • Mental Health
  • Neurological Disorder
  • Market Size
  • Eisai Co., Ltd.
  • GW Pharmaceuticals plc

Figure ##.

  • Vitamin
  • United States
  • Amway Corporation
  • Chobani LLC
  • Herbalife Ltd.

IT PROVIDES PHARMACEUTICALS IN CANCER, NEUROSCIENCE, INFECTION, IMMUNOLOGY, OPHTHALMOLOGY, CARDIOVASCULAR AND METABOLISM, IMMUNOLOGY, HEMATOLOGY, HEMOPHILIA AND RESPIRATORY DISEASE AREAS.

  • Vitamin
  • Brazil
  • Russia
  • Forecast
  • Market Segment

According to the Colombian Association of Allergy and Immunology there are between four and five million Colombians suffering from food allergies.

  • Vitamin
  • Colombia
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Tecnoquímicas SA

According to the Sociedade Portuguesa de Alergologia e Imunologia Clínica (Portuguese Society of Allergology and Clinical Immunology - SPAIC), more and more people are suffering from respiratory allergies, especially rhinitis.

  • Vitamin
  • Portugal
  • Demand
  • GlaxoSmithKline plc
  • Unipessoal, Lda

Figure ## presents the diagnosed prevalent cases of MG in 2018 and 2028.

  • Epidemiology
  • Hospital
  • Neurological Disorder
  • United States
  • Forecast

IT PROVIDES PHARMACEUTICALS IN CANCER, NEUROSCIENCE, INFECTION, IMMUNOLOGY, OPHTHALMOLOGY, CARDIOVASCULAR AND METABOLISM, IMMUNOLOGY, HEMATOLOGY, HEMOPHILIA AND RESPIRATORY DISEASE AREAS.

  • Vitamin
  • East Asia
  • Forecast
  • Beckman Coulter, Inc.
  • F. Hoffmann-La Roche Ltd.

THE COMPANY STATES THAT THESE ARE DESIGNED AS PER THE NORMS OF DIN ISO ##-## AND ##-##.

  • Neurological Disorder
  • World
  • Forecast
  • Antares Pharma, Inc.
  • Sanofi S.A.
  • NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE, PHARMACEUTICALS & HEALTHCARE, DEALS BY THERAPY AREA, 2012 TO YTD 2018

Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Pharmaceuticals and Healthcare No. of Deals ## ## ## ## ## ## Deal Value (US$ million) NA NA NA NA NA NA Note: Deals include all announced pharmaceuticals & h

  • Mental Health
  • Neurological Disorder
  • Pathology
  • Stroke
  • United States

Revati holds a PhD in Tumor Immunology from the Tata Cancer Research Institute in Mumbai, India.

  • Cell Therapy
  • Neurological Disorder
  • United States
  • Asterias
  • Neuralstem, Inc.

Scale = ##-##, where ## is low impact, and ## is high impact.

  • Neurological Disorder
  • World
  • Market Size
  • QIAGEN N.V.
  • Thermo Fisher Scientific, Inc.

Some players compete by increasing their range of products and employing direct sales agents, who deal with retailers one-on-one.

  • OTC
  • Vitamin
  • Cameroon
  • Demand
  • Sanofi S.A.
  • GLOBAL MARKETS DIRECT REPORT COVERAGE

The drug candidate is a substituted ##, ##-dihydro-[##, ##, ##]triazolo[##, ##-a]pyrazin-##(##H)-one that acts by targeting P##X## receptor.

  • Neurological Disorder
  • Therapy
  • World
  • Product Initiative
  • Biosceptre International Limited

With three major research centres located in Germany, Austria and the US, the company' s main areas of development are focused on immunology and diseases of the respiratory, cardio-metabolic and central nervous systems as well as non-clinical drug development.

  • Vitamin
  • Brazil
  • Demand
  • Farmacêutica Ltda
  • Sanofi S.A.

April ##, 2017, ##:## - ##:## p. m.

  • Neurological Disorder
  • Pharmaceutical
  • United States
  • World
  • Product Initiative

The company will however focus new product development on Rx medicines, with a focus on rare diseases, diabetes, cardiovascular diseases and immunology.

  • OTC
  • Vitamin
  • Italy
  • Demand
  • Angelini Group
  • NEUROMYELITIS OPTICA (DEVIC'S SYNDROME) - PIPELINE BY CHUGAI PHARMACEUTICAL CO LTD, H2 2019
  • NEUROMYELITIS OPTICA (DEVIC'S SYNDROME) - PIPELINE BY LFB SA, H2 2019

The company offers immunology, haemostasis, perinatal and intensive care and adverse effect reporting products.

  • Monoclonal Antibody
  • Neurological Disorder
  • United States
  • Product Initiative
  • Alexion Pharmaceuticals, Inc.
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF MYASTHENIA GRAVIS TO IMMUNOLOGY CLINICAL TRIALS
  • CLINICAL TRIALS BY E7 COUNTRIES: PROPORTION OF MYASTHENIA GRAVIS TO IMMUNOLOGY CLINICAL TRIALS

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## Alexion Pharmaceuticals Inc ## ## ## ## ## ## ## Astellas Pharma Inc ## ## ## ## ## ## ## Cytokinetics Inc ## ## ## ## ## ## ## Quintiles IMS Holdings Inc ## ## ## ## ## ## ## CuraVac Inc ## ## ## ## ## ## ## CSL Ltd ##

  • Clinical Trial
  • Monoclonal Antibody
  • Neurological Disorder
  • World
  • Product Initiative